TABLE 2.
Parameter | Entire Cohort | Locally Controlled | GTV D95 High Dose |
PTV D95 High Dose |
Local Failure |
GTV D95 Low Dose |
PTV D95 Low Dose |
---|---|---|---|---|---|---|---|
No. of lesions | 811 | 783 | 749 | 771 | 28 | 62 | 40 |
No. of local failures (crude %) | 28 (3.5%) | 19 (2.5%) | 18 (2.3%) | 9 (14.5%) | 10 (25%) | ||
GTV in cm3 | 13.4 (0.1–642) | 12.9 (1–642) | 14 (1–642) | 13 (1–642) | 26 (2–147) | 11 (1–326) | 14 (1–326) |
GTV D95 in cGy | 2320 (1334–2850) | 2333 (1339–2858) | 2356 (1834–2585) | 2346 (1457–2858) | 2029 (1334–2497) | 1709 (1330–1830) | 1856 (1334–2688) |
GTV V95 in % | 98 (69–100) | 98 (46–100) | 99 (69–100) | 98 (46–100) | 94.8 (56–100) | 83 (46–100) | 94.5 (56–100) |
PTV in cm3 | 65.9 (4–904) | 65.9 (4–904) | 66 (5–904) | 66 (4–904) | 72.3 (12.7–1736) | 28 (4–503) | 52 (8–503) |
PTV D95 in cGy | 2205 (1414–2864) | 2220 (1142–2864) | 2356 (1142–2864) | 2240 (1742–2858) | 1930 (1416–2424) | 1709 (1386–2167) | 1644 (1142–1734) |
PTV V95 in % | 94.8 (80–100) | 94.9 (80–100) | 95 (80–100) | 95 (82–100) | 91.6 (80–100) | 89 (80–100) | 90 (80–100) |
Except in the first and second rows, the values in parentheses represent the range. Numbers in boldface type represent the median values.